Skip to main content
Psychedex

4-HO-MPT

4-hydroxy-N-methyl-N-propyltryptamine

1Provenance card

the boundary, as counts

Sources

1710 with DOI

3 strong · 8 moderate · 6 weak

Compilations

12026-05-10T21:48:00.606Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:30:02.808Z

notice · info card · emergency

Searches

253 with no results

queries and counts on the build

Claims checked

4232 supported

32 supported · 10 not

Correspondence

0received

consent field ships in Phase 4

Edges

173

derivations recorded for this entity

Complete over 17 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/4-ho-mpt/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-07srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
  5. 2026-09-07srcPharmacokinetics of N,N-dimethyltryptamine in Humans
  6. 2026-09-07srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
  7. 2026-09-07srcStudy of the in vitro and in vivo metabolism of 4-HO-MET
  8. 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
  9. 2026-09-07srcStructure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
  10. 2026-09-07srcReceptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice
  11. 2026-09-07srcBiomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations
  12. 2026-09-07srcRecreational use, analysis and toxicity of tryptamines.
  13. 2026-09-07srcHuman Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by LC-HRMS/MS
  14. 2026-09-07srcHallucinogen Persisting Perception Disorder After Psilocybin Consumption: A Case Study
  15. 2026-09-07srcPsychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents.
  16. 2026-09-07srcCircular 001/2015: a change to the Misuse of Drugs Act 1971: control of tryptamines
  17. 2026-09-07src4-HO-MPT — Erowid vault
  18. 2026-09-07src4-HO-MPT
  19. 2026-09-07src4-Hydroxy MPT (CAS 763035-03-6) — Cayman Chemical product #26493
  20. 2026-09-07src4-HO-MPT — PsychonautWiki
  21. 2026-09-04issueIssued emergency
  22. 2026-09-04issueIssued info_card
  23. 2026-09-04issueIssued notice
  24. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  25. 2026-06-04publicationPublication — backfill
  26. 2026-05-10revisionRevision 1
  27. 2026-05-10absenceSearched OpenAlex for "4-HO-MPT meprocin tryptamine" — no results
  28. 2026-05-10absenceSearched PubMed for "4-OH-MPT metabolism in vitro human" — no results
  29. 2026-05-10absenceSearched ClinicalTrials.gov for "4-HO-MPT tryptamine psychedelic" — no results
  30. 2026-05-10genGeneration — pipeline-v5 · with 3 morepipeline-v5
  31. 2026-05-10rungeneration run

The same entries, as forms: six forms.